DBZ (RMML-00120210)
Cat. No.: RMML-00120210
Category: Inhibitors & Activators
INQUIRY
1 mg
5 mg
DBZ is a diazepine inhibitor of γ-secretase, which cleaves transmembrane proteins including Notch, amyloid precursor protein. DBZ blocks the cleavage of Notch into its active signalling effector, Notch intracellular domain, with an IC₅₀ of 1. 7 nM. Enables reprogramming of human keratinocytes to induced pluripotent stem cells in the absence of oncogenic reprogramming factors KLF4 and c-MYC. Induces intestinal cell apoptosis & goblet cell metaplasia in rats; attenuates the reduction of paneth cells and goblet cells caused by tuberous sclerosis 2. Improves glucose homeostasis and mediates a metabolic shift toward the utilization of fat as the energy source in mice. Induces differentiation of intestinal adenomas in Apc(Min) transgenic mice. Decreases the production of inflammatory cytokines by alloreactive T cells after bone marrow transplantation in mice, reducing the severity of graft-versus-host disease.
Product Features
| Purity | ≥ 98% |
|---|---|
| Applications | Reprogramming |
| Cross Reactivity | Human, Mouse, Non-Human Primate, Other, Rat |
Compound Information
| Target Pathways | Notch |
|---|---|
| CAS Number | 209984-56-5 |
| Molecular Formula | C₂₆H₂₃F₂N₃O₃ |
Storage & Shipping
| Handling | Refer to SDS for further information. |
|---|
For research use only. Not for clinical use.